def explain_tnbc_treatment_benefit():
    """
    This function explains which population group benefits from PD-1 inhibitors
    in Triple Negative Breast Cancer (TNBC) based on clinical trial data.
    """

    # Explanation based on key clinical trial results (e.g., KEYNOTE-355).
    # These trials compared chemotherapy plus a PD-1 inhibitor against chemotherapy alone.

    # Finding 1: In the PD-L1-positive population.
    # Result: Statistically significant improvement in overall survival was observed.
    pd_l1_positive_benefit = "prolonged overall survival"

    # Finding 2: In the intention-to-treat (ITT) population (all patients).
    # Result: A statistically significant overall survival benefit was NOT observed.
    itt_population_benefit = "not statistically significant"

    # Finding 3: In the PD-L1-negative population.
    # Result: No significant benefit was observed.
    pd_l1_negative_benefit = "no significant benefit"

    print("Analysis of PD-1 Inhibitor Efficacy in Triple Negative Breast Cancer:")
    print("-" * 65)
    print(f"1. In the Intention-to-treat population, the overall survival benefit was: {itt_population_benefit}.")
    print(f"2. In the PD-L1-positive population, the treatment presented: {pd_l1_positive_benefit}.")
    print(f"3. In the PD-L1-negative population, there was: {pd_l1_negative_benefit}.")
    print("-" * 65)
    print("\nConclusion: The data clearly shows that the prolonged overall survival benefit is demonstrated in the PD-L1-positive population.")
    print("Therefore, the correct choice is B.")

if __name__ == "__main__":
    explain_tnbc_treatment_benefit()